Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Johnson
Dale N Gerding

Showing results (141-150 of 283) with videos related to

Pageof 29
Sort By:
Cancer Treatment and Research|April 8, 2014
Enteric infectionsMichael Wang, Stuart Johnson
Journal of Clinical Microbiology|February 27, 2015
Differential immunodetection of toxin B from highly virulent Clostridium difficile BI/NAP-1/027Nira R Pollock, Linan Song, Mingwei Zhao, et al.
Antimicrobial Agents and Chemotherapy|June 9, 2016
Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult PatientsLarry K Kociolek, Dale N Gerding, James R Osmolski, et al.
Open Forum Infectious Diseases|June 12, 2020
Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of <i>Clostridioides</i> (<i>Clostridium</i>) <i>difficile</i> InfectionErik R Dubberke, Dale N Gerding, Ciarán P Kelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2019
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY IIEllie J C Goldstein, Diane M Citron, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile InfectionThomas Louie, Carl Erik Nord, George H Talbot, et al.
BMC Infectious Diseases|April 23, 2016
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databasesMargaret A Olsen, Yinong Young-Xu, Dustin Stwalley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2015
Prevention of Clostridium difficile Infection With ProbioticsCharlesnika T Evans, Stuart Johnson
Current Opinion in Gastroenterology|December 5, 2012
Important clinical advances in the understanding of Clostridium difficile infectionSusan M Pacheco, Stuart Johnson
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|August 1, 2013
Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungwormGerald S Murphy, Stuart Johnson
Pageof 29

Showing results (141-150 of 283) with videos related to

Sort By:
Pageof 29
Cancer Treatment and Research|April 8, 2014
Enteric infectionsMichael Wang, Stuart Johnson
Journal of Clinical Microbiology|February 27, 2015
Differential immunodetection of toxin B from highly virulent Clostridium difficile BI/NAP-1/027Nira R Pollock, Linan Song, Mingwei Zhao, et al.
Antimicrobial Agents and Chemotherapy|June 9, 2016
Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult PatientsLarry K Kociolek, Dale N Gerding, James R Osmolski, et al.
Open Forum Infectious Diseases|June 12, 2020
Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of <i>Clostridioides</i> (<i>Clostridium</i>) <i>difficile</i> InfectionErik R Dubberke, Dale N Gerding, Ciarán P Kelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2019
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY IIEllie J C Goldstein, Diane M Citron, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2015
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile InfectionThomas Louie, Carl Erik Nord, George H Talbot, et al.
BMC Infectious Diseases|April 23, 2016
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databasesMargaret A Olsen, Yinong Young-Xu, Dustin Stwalley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2015
Prevention of Clostridium difficile Infection With ProbioticsCharlesnika T Evans, Stuart Johnson
Current Opinion in Gastroenterology|December 5, 2012
Important clinical advances in the understanding of Clostridium difficile infectionSusan M Pacheco, Stuart Johnson
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|August 1, 2013
Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungwormGerald S Murphy, Stuart Johnson
Pageof 29